What is LOPJLB’s current signal on VYGR?

LOPJLB’s latest quantitative signal on Voyager Therapeutics, Inc. (VYGR) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is VYGR in?

Voyager Therapeutics, Inc. (VYGR) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Voyager Therapeutics, Inc. (VYGR) do?

Voyager Therapeutics, Inc. operates as a gene therapy company, concentrating its efforts on developing innovative treatments and pioneering advanced platform technologies. Its leading clinical asset, VY-AADC, is presently undergoing an open-label Phase 1 clinical trial for the management of Parkinson's disease. The company's preclinical portfolio is extensive, featuring VY-SOD102 for amyotrophi…

Where is Voyager Therapeutics, Inc. based / listed?

Voyager Therapeutics, Inc. is based in US, listed on NASDAQ.

Voyager Therapeutics, Inc. (VYGR)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.37-4.05%Close

SELLCRISIS · day 12

[SCORES & PROFILE]

FUND: 0
VALUE: 5
GROWTH: 26
GARP: 3
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-34.8%

REV YoY-

ROE-57.9%

EPS YoY-

ROA-54.5%

GROSS

-104

-340

NET

-313

[VALUATION]

P/E TTM-1.36

P/E FWD-

SECTOR PE20.12

INDUSTRY PE13.79

P/B0.96

P/FCF-

EV/EBITDA-1.41

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E21.10

ALTMAN Z-

CURR RATIO7.51

ND/EBITDA-

BETA1.28

Voyager Therapeutics, Inc. (VYGR)

Key stats

Industry peers

Prediction markets

FUNDAMENTALS

Company news